Complete Scientific Guide to Vitamin D3: Evidence, Safety, and Use

Medical disclaimer: This article is for education only. It is not medical advice and does not diagnose, treat, or prevent any disease. Talk to a qualified healthcare professional before starting or changing any supplement, especially if you are pregnant, have a medical condition, or take medicines.

Sunlight on your skin, a plate of salmon, and a small softgel can all lead to the same molecule: vitamin D3. It is one of the few nutrients your body can make for itself, and one of the few that works more like a hormone than a classic vitamin. That unusual identity explains why vitamin D3 attracts so much attention, and also why headlines swing between "miracle nutrient" and "overhyped supplement." This guide is a complete, plain-language scientific reference on vitamin D3. It covers where it comes from, how it is made, how the body activates it, what clinical trials show, how much has been studied, and how to judge safety and quality.

We separate established findings from uncertain evidence and from hypotheses, so you can see exactly how strong each claim is. Whether you are a curious reader, a clinician, or a researcher, use the sections below as a map.

Vitamin D3 Quick Facts and Executive Summary

Item	Quick fact
Chemical name	Cholecalciferol (vitamin D3), a secosteroid
Made in the body from	7-dehydrocholesterol in skin, after exposure to ultraviolet B (UVB) light
Active hormone	Calcitriol, also written 1,25-dihydroxyvitamin D
Blood marker of status	25-hydroxyvitamin D, written 25(OH)D
Unit conversion	1 microgram (mcg) equals 40 international units (IU); 1 ng/mL equals 2.5 nmol/L
U.S. Recommended Dietary Allowance	600 IU (15 mcg) for ages 1 to 70; 800 IU (20 mcg) above age 70
U.S. Tolerable Upper Intake Level	4,000 IU (100 mcg) per day for adults and ages 9 and up
Strongest evidence	Preventing rickets and osteomalacia; correcting deficiency
Mixed or limited evidence	Fractures and falls, infections, cancer, heart disease, diabetes, mood
Main cautions	Excess intake can cause high blood calcium; large infrequent doses may be harmful; label accuracy varies

In short, vitamin D3 is essential for calcium absorption and bone mineralization, and its receptor is found in many other tissues. Severe deficiency causes rickets in children and osteomalacia in adults. Correcting a true deficiency is clearly beneficial. For people who already have adequate levels, large randomized trials of vitamin D3 supplements have mostly found little or no benefit for preventing cancer, cardiovascular disease, or fractures. Some outcomes, such as respiratory infections in deficient people and autoimmune disease, show interesting signals that need confirmation.

The reasonable takeaway is neither "everyone needs high doses" nor "supplements are useless." The right amount depends on skin exposure, diet, age, skin pigmentation, body size, health conditions, and starting blood level. Safe intake ranges are well defined, and sticking within them is sensible for most people.

What Is Vitamin D3? Definition and Identity

Vitamin D3 is the form of vitamin D produced by animals, including humans. It is also the form most often sold in supplements. The other main form, vitamin D2 (ergocalciferol), is made by plants and fungi. Both are called vitamin D, and both can be activated by the body, but they are not identical, and D3 has generally been shown to raise blood 25(OH)D more effectively than D2 (Armas et al., 2004; Tripkovic et al., 2012).

Vitamin D is called a vitamin because it is required in small amounts and, in the absence of enough sun, must come from food or supplements. Yet in a strict biochemical sense it behaves like a prohormone. The molecule you swallow or make in skin has little activity on its own. It must be converted in the liver and then in the kidney or other tissues into calcitriol, which binds to a nuclear receptor and changes gene expression. This hormone-like system also includes regulation by parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), calcium, and phosphate.

Two features of this identity matter for everyday decisions. First, vitamin D3 status is measured as 25(OH)D, because this form circulates at stable levels and reflects intake and skin production over weeks. Second, sun exposure counts as a source. Intake from food and supplements is only part of the picture, which makes recommendations vary from person to person.

Cholecalciferol Classification: Botanical and Chemical Identity

Cholecalciferol is a secosteroid, meaning a steroid in which one of the four rings has been broken. In vitamin D, the bond between carbons 9 and 10 of the cholesterol-like ring system is cleaved by UVB light, giving a flexible, open structure. Its systematic description is 9,10-secocholesta-5,7,10(19)-trien-3-beta-ol, and its molecular formula is C27H44O with a molecular weight of about 384.6.

Property	Vitamin D3 (cholecalciferol)	Vitamin D2 (ergocalciferol)
Natural source	Animal tissues; human skin; some lichens	Plants and fungi, such as UV-exposed mushrooms
Precursor	7-dehydrocholesterol	Ergosterol
Side chain	Saturated, no extra methyl group	Extra double bond and methyl group
Typical supplement use	Most common worldwide	Used in some prescription products and fortified foods
Raising 25(OH)D	Generally more effective	Generally less effective

The chemical classification places cholecalciferol among fat-soluble vitamins, together with vitamins A, E, and K. Because it dissolves in fat, it is stored in body fat and liver, absorbed with dietary fat, and can build up if intake is excessive.

In terms of botanical or biological classification, vitamin D3 is not tied to a single species. It is a single chemical entity found in animals and in a few non-animal sources. Commercial vitamin D3 comes mainly from sheep's wool grease (lanolin), which contains 7-dehydrocholesterol, and from certain lichens (for example Cladonia and Roccella species) for vegan products. Some fish liver oils also contain natural vitamin D3. The source organism affects labeling, allergen status, and consumer choice, but the final purified cholecalciferol molecule is the same.

Origin, Cultivation, and Sources of Vitamin D3

Vitamin D3 comes from four routes: the skin, food, fortified foods, and supplements.

Skin production. When UVB radiation with wavelengths of about 290 to 315 nanometers reaches the skin, it converts 7-dehydrocholesterol in the epidermis to previtamin D3. Body heat then slowly converts previtamin D3 to vitamin D3, which enters the blood bound to vitamin D binding protein. Skin production is self-limiting, since prolonged exposure converts previtamin D3 into inactive products, so sunlight cannot cause vitamin D toxicity (Holick, 2007; Wacker and Holick, 2013).

Production depends on several factors:

• Latitude and season. At higher latitudes, UVB is too weak for effective skin synthesis during much of the winter.
• Time of day. UVB is strongest near midday.
• Skin pigmentation. Melanin absorbs UVB, so people with darker skin need longer exposure to make the same amount.
• Age. Older skin contains less 7-dehydrocholesterol, so synthesis is lower.
• Sunscreen, clothing, and indoor living. All reduce UVB reaching the skin.
• Air pollution and cloud cover. These scatter and block UVB.

Because skin exposure also increases the risk of skin cancer, public health bodies do not recommend unprotected sun exposure as a way to raise vitamin D.

Food sources. Few foods contain much vitamin D. The richest natural sources are fatty fish such as salmon, trout, mackerel, and sardines, and fish liver oils. Egg yolks, beef liver, and some cheeses contain smaller amounts. Mushrooms exposed to UV light contain vitamin D2 and, in some cases, other forms.

Fortified foods. In many countries, milk, some plant milks, breakfast cereals, margarine, and infant formula are fortified with vitamin D2 or D3. Fortification is often a major source in the diet.

Cultivation and farming. For commercial supply, wool grease is collected during the washing of sheep's wool, and lichens used for vegan D3 are harvested or cultivated under controlled conditions. Because lichens grow slowly, responsible sourcing and supply stability are ongoing concerns. Yeast and mushroom irradiation produce vitamin D2, not D3, and some animal feed uses plant-derived calcitriol glycosides, which are not typical in human supplements.

History and Traditional Use of Vitamin D3

The story of vitamin D is a story of rickets. Children in crowded, smoky industrial cities of seventeenth-century Europe developed bowed legs, soft bones, and delayed growth, and the condition was described in detail by Whistler and Glisson in the 1600s. For centuries, practical remedies came from folk practice. Cod liver oil was used in northern Europe and Britain, and sunlight and fresh air were advised long before scientists understood why (Rajakumar, 2003).

The scientific breakthroughs came quickly in the early twentieth century. Niels Finsen received a Nobel Prize in 1903 for ultraviolet light therapy. In 1919, Kurt Huldschinsky showed that ultraviolet lamp treatment healed rickets, and Edward Mellanby produced rickets in dogs through diet and cured it with cod liver oil. In 1922, McCollum and colleagues showed that the anti-rachitic factor in cod liver oil was distinct from vitamin A, and it was named vitamin D (McCollum et al., 1922). In the 1920s, Harry Steenbock found that irradiating foods created anti-rachitic activity, which led to fortification programs. Adolf Windaus received the 1928 Nobel Prize in Chemistry for work on sterols and their relationship to vitamins, and later work identified vitamin D3 as the product of irradiated 7-dehydrocholesterol (Wolf, 2004).

In the 1970s, researchers discovered that the kidney converts 25(OH)D into a more potent hormone, 1,25-dihydroxyvitamin D (Fraser and Kodicek, 1970). The vitamin D receptor was later identified, and the field expanded beyond bone to immunity, muscle, and cell growth.

Traditional use was practical and not scientific in the modern sense. People used cod liver oil, sun exposure, and in some regions fish and organ meats. These practices worked for rickets, mostly because of vitamin D, although traditional claims for other conditions were not tested by modern trials.

Modern Nutraceutical Use of Vitamin D3 Supplements

Vitamin D3 supplements are among the most widely used dietary supplements in many countries. Consumers use them for bone health, muscle function, immune support, mood, and general wellness, often because of reported low blood levels or limited sun exposure. Typical products supply 400 to 5,000 IU per serving, and some supply 10,000 IU or more per capsule or per week.

The nutraceutical market includes many formats and combinations:

• Single-ingredient vitamin D3 in softgels, tablets, drops, sprays, and gummies.
• Combinations with calcium, common in bone health products.
• Combinations with vitamin K2, marketed for directing calcium into bone, although the evidence for added benefit is still developing.
• Combinations with magnesium, because magnesium is needed for enzymes that activate vitamin D.
• Multivitamins and prenatal formulas, usually with modest doses.
• Fortified foods and infant drops. Breastfed infants are commonly advised to receive 400 IU daily (Wagner and Greer, 2008).

In medicine, high-dose vitamin D (often D2 in the United States, and D3 in many other countries) is prescribed to treat deficiency. Calcifediol and activated forms such as calcitriol are used in kidney disease and certain endocrine conditions, and vitamin D analogs such as calcipotriol are applied to the skin for psoriasis. These drug uses are distinct from nutritional supplementation.

An important message for consumers is that the sheer popularity of vitamin D3 supplements is not proof of benefit for everyone. Testing and dosing should reflect individual circumstances, and the trial evidence discussed below shows that supplements help most clearly in people who are deficient.

Chemical Composition of Vitamin D3 and Its Formulations

Pure cholecalciferol is a white crystalline solid that is practically insoluble in water and soluble in oils and organic solvents. It is sensitive to light, heat, oxygen, and acids, which cause isomerization and oxidation. Because of this fragility, supplement makers formulate it carefully.

Formulation type	Typical composition	Notes
Oil-based softgel	Cholecalciferol dissolved in olive, sunflower, or medium-chain triglyceride oil, in a gelatin or plant-based shell	Common; fat carrier supports absorption
Tablet or capsule powder	Cholecalciferol dispersed in a matrix of starch, sucrose, gelatin, or other carriers (beadlets) with antioxidants	Stable; carrier choice may matter for allergies
Liquid drops	Oil or aqueous emulsion	Flexible dosing; used for infants and adults
Oral spray	Emulsified or oil-based	Absorption claims vary
Gummies	Cholecalciferol with gelatin or pectin, sugars, flavors	Potency can drift during storage
Lichen-derived vegan D3	Cholecalciferol isolated from lichen	Same molecule, plant-based label

Besides cholecalciferol itself, finished products contain excipients (fillers, binders, flavors, colors), antioxidants such as tocopherols, and sometimes cofactors such as magnesium or vitamin K2. Natural sources such as cod liver oil also supply vitamin A and omega-3 fatty acids. The amount per serving is declared in micrograms and, on many labels, also in IU.

Under storage, vitamin D3 can slowly degrade. Manufacturers often add a small overage, which means putting in more than the label amount so that the product still meets its claim at the end of its shelf life. When overages are too large or manufacturing is poorly controlled, actual content may exceed the label.

Key Active Compounds: Cholecalciferol, Calcifediol, and Calcitriol

The vitamin D system includes a family of molecules, each with a different role.

Cholecalciferol (vitamin D3). The parent compound, made in skin or taken orally. It has low biological activity until converted.

Calcifediol (25-hydroxyvitamin D3, or 25(OH)D3). The liver enzyme CYP2R1, along with others such as CYP27A1, adds a hydroxyl group at position 25. Calcifediol is the main circulating form and the standard marker of vitamin D status. It has a half-life of roughly two to three weeks (Jones, 2008). Calcifediol is also available as a prescription or supplement in some countries and is thought to be absorbed more rapidly than cholecalciferol.

Calcitriol (1,25-dihydroxyvitamin D3). The kidney enzyme CYP27B1 adds a second hydroxyl group at position 1, forming the active hormone. Calcitriol binds the vitamin D receptor with very high affinity and circulates at about a thousand times lower concentration than 25(OH)D, with a half-life of hours. Many other tissues, including immune cells, skin, and the intestinal lining, also express CYP27B1 and can make calcitriol locally (Bikle, 2014).

24,25-dihydroxyvitamin D and calcitroic acid. The enzyme CYP24A1 breaks down both 25(OH)D and calcitriol to inactive products, which keeps the system in balance. Variants that reduce CYP24A1 function can raise the risk of high calcium.

Vitamin D binding protein (DBP). Not a vitamin D compound, but a key partner. DBP carries most circulating vitamin D metabolites, and only a very small free fraction enters cells easily. Genetic differences in DBP may affect how total 25(OH)D relates to biologically available vitamin D.

Vitamin D receptor (VDR). A nuclear receptor that pairs with the retinoid X receptor and binds to DNA elements to regulate gene transcription.

Understanding this chain explains why very high calcitriol is not the goal of supplements. The body tightly controls calcitriol, so supplements raise 25(OH)D mainly as a reservoir.

Extraction and Processing of Vitamin D3 Supplements

Most commercial vitamin D3 is made by a semi-synthetic process that mimics what happens in skin.

1. Raw material collection. Wool grease (crude lanolin) is recovered from the washing of sheep's wool. It is rich in cholesterol, from which 7-dehydrocholesterol can be produced.
2. Purification and conversion. The lanolin is processed, often by saponification and chemical steps, to isolate cholesterol, which is converted to 7-dehydrocholesterol.
3. UVB irradiation. A solution of 7-dehydrocholesterol is exposed to controlled ultraviolet light, which opens the ring and forms previtamin D3.
4. Thermal conversion. Gentle heating transforms previtamin D3 into vitamin D3. Reaction conditions are controlled to limit unwanted by-products such as lumisterol and tachysterol.
5. Purification and crystallization. Chromatography and crystallization produce high-purity crystalline cholecalciferol.
6. Formulation. The crystals are dissolved in oil for softgels and drops, or dispersed into beadlets with protective matrices and antioxidants for tablets, capsules, and fortified foods.
7. Quality testing. High-performance liquid chromatography (HPLC) confirms identity, purity, and potency, and stability studies set the shelf life.

Vegan vitamin D3 follows a different path. Lichens are harvested or cultivated, extracted with solvents, and purified to yield cholecalciferol, which is then formulated like other D3. Some producers use plant-derived sterols.

Natural food-based sources, such as fish liver oil, are produced by pressing and refining the liver, followed by steps that remove contaminants and standardize vitamin A and D content. Vitamin D2 is made by irradiating ergosterol from yeast or fungi.

Because the process involves light, heat, and solvents, residue control and light-protected manufacturing are critical parts of good practice.

Standardization and Potency of Vitamin D3 Supplements

Potency is expressed in micrograms (mcg) or international units (IU). The conversion is fixed: 1 mcg of vitamin D equals 40 IU, so 25 mcg equals 1,000 IU. Many labels in the United States now list micrograms first, following the revised Nutrition Facts format, and some still add IU in parentheses. When comparing vitamin D3 supplements, check the unit carefully, because a mix-up between mcg and IU is a common source of error.

Several layers of standardization apply:

• Product potency. Reputable manufacturers confirm vitamin D3 content by HPLC and release only batches that meet a specified range of the label claim.
• Pharmacopeial standards. The United States Pharmacopeia and the European Pharmacopoeia publish monographs for cholecalciferol and for dosage forms, with identity, purity, and potency criteria.
• Stability. Because the molecule degrades with heat, light, and oxygen, potency is checked over the shelf life, not only at release.
• Blood level standardization. For clinical use, the standard measure is serum 25(OH)D. Laboratory methods differ, and liquid chromatography with tandem mass spectrometry (LC-MS/MS) is considered the reference approach. International programs such as the Vitamin D Standardization Program aim to make results comparable across laboratories (Sempos et al., 2018).

Even with standardization, the blood level targets themselves are debated. The Institute of Medicine (now the National Academy of Medicine) concluded in 2011 that a 25(OH)D of about 20 ng/mL (50 nmol/L) meets the needs of most people, that levels below 12 ng/mL (30 nmol/L) indicate a risk of deficiency, and that levels above about 50 ng/mL (125 nmol/L) may carry risk (IOM, 2011; Ross et al., 2011). The Endocrine Society's 2011 guideline defined deficiency as below 20 ng/mL and insufficiency as 21 to 29 ng/mL (Holick et al., 2011). These differences reflect different goals, with one focused on population needs and the other on clinical care of at-risk patients. Readers should expect their own laboratory report to show a reference range, and should discuss the result with a clinician.

Mechanisms of Action of Vitamin D3

Vitamin D3 acts mostly through its hormone form, calcitriol. The central mechanism is genomic signaling through the vitamin D receptor (VDR).

1. Genomic signaling. Calcitriol enters the cell and binds the VDR in the nucleus. The VDR pairs with the retinoid X receptor, binds to vitamin D response elements on DNA, and recruits co-regulators to switch genes on or off. Hundreds of genes have been reported to respond, although the exact number varies by cell type (Christakos et al., 2016).

2. Calcium and phosphate balance. In the intestine, calcitriol increases the production of calcium transport proteins, including the channel TRPV6 and the binding protein calbindin, which raises calcium absorption. In people with adequate vitamin D, the gut absorbs roughly 30 to 40 percent of dietary calcium, compared with about 10 to 15 percent when vitamin D is lacking (Holick, 2007). In the kidney, calcitriol supports calcium reabsorption. In bone, it influences cells that build and break down bone, partly through RANKL signaling, and it supports mineralization by keeping calcium and phosphate available.

3. Hormonal feedback. Low blood calcium raises parathyroid hormone (PTH), which stimulates CYP27B1 in the kidney to make more calcitriol. Calcitriol then reduces PTH production and raises FGF23, which lowers phosphate reabsorption. When 25(OH)D is low for long periods, PTH rises (secondary hyperparathyroidism), which can accelerate bone loss.

4. Immune modulation. Immune cells express VDR and CYP27B1, so they can make and respond to calcitriol locally. Calcitriol induces antimicrobial peptides such as cathelicidin in some cells, tends to push dendritic cells toward a more tolerant state, and can reduce certain inflammatory T-cell responses while supporting regulatory T cells (Bikle, 2014). These effects are consistent with a role in both defense and immune balance, although how much they matter at supplement doses is still being tested.

5. Cell growth and differentiation. In laboratory studies, calcitriol slows proliferation and promotes differentiation in many cell types, which has drawn interest in cancer and skin disease research.

6. Muscle, heart, and metabolism. VDR is present in muscle, vascular tissue, pancreas, and fat. Proposed actions include effects on muscle fiber function, suppression of renin, and influence on insulin secretion and sensitivity. These are plausible and supported by cell and animal work, but human trial evidence is mixed.

7. Rapid, non-genomic effects. Some responses occur within minutes, apparently through membrane-associated receptors, and these are less well characterized.

Control by catabolism. The enzyme CYP24A1 inactivates 25(OH)D and calcitriol, creating a built-in brake that limits the activity of the hormone. This is why the body can handle sun exposure safely but can be overwhelmed by very large oral doses.

Pharmacokinetics of Cholecalciferol

Pharmacokinetics describes absorption, distribution, metabolism, and elimination.

Absorption. Cholecalciferol is absorbed in the small intestine together with dietary fat. It is incorporated into mixed micelles with bile salts, taken up by intestinal cells (with help from transporters such as SR-B1, CD36, and NPC1L1), packaged into chylomicrons, and carried through the lymph into the blood. Absorption efficiency is generally considered to be moderate to high, but it varies with fat intake, bile flow, and gut health.

Distribution and storage. In blood, most vitamin D and its metabolites are bound to vitamin D binding protein, with a smaller share bound to albumin, and only a tiny fraction free. Vitamin D3 is stored in body fat and, to a lesser degree, in muscle and liver. This storage slows its release and is one reason why people with higher body fat often show lower blood levels for the same dose, as the vitamin is diluted into a larger pool.

Metabolism. In the liver, CYP2R1 and related enzymes convert vitamin D3 to 25(OH)D. In the kidney, and in other tissues, CYP27B1 converts 25(OH)D to calcitriol. CYP24A1 breaks them down to inactive products. Magnesium is needed as a cofactor for these enzymes (Uwitonze et al., 2018).

Half-lives. Vitamin D3 itself disappears from the blood relatively quickly, over about a day or two after a dose, while 25(OH)D has a half-life of roughly two to three weeks. Calcitriol lasts only hours (Jones, 2008).

Time to steady state. After starting a stable daily dose, 25(OH)D typically rises over several weeks and reaches a plateau in about two to three months, and sometimes longer (Heaney et al., 2003).

Dose response. As a rough guide, each additional 100 IU per day raises 25(OH)D by about 0.5 to 1 ng/mL (roughly 1 to 2.5 nmol/L), with large individual variation and smaller gains at higher starting levels (Mazahery and von Hurst, 2015). Body weight, baseline status, age, genetics, and sun exposure all matter.

Elimination. Metabolites are excreted mainly in bile and feces, with a small share in urine. Very little unchanged vitamin D appears in urine, so the kidney does not clear excess quickly, which helps explain why overdoses can persist.

Bioavailability of Vitamin D3 Supplements

Bioavailability is the share of a dose that reaches circulation in a usable form. For vitamin D3 supplements, several factors have been studied.

Taking it with fat. Because vitamin D is fat-soluble, food that contains fat improves absorption. A small study found that taking vitamin D with the largest meal of the day raised 25(OH)D by about 50 percent over two to three months compared with taking it on an empty stomach or with a small meal (Mulligan and Licata, 2010). Another study showed that vitamin D3 absorbed better with a high-fat meal than with a fat-free one (Dawson-Hughes et al., 2015).

Vehicle and form. A systematic review concluded that oil-based preparations were generally more effective than powder or ethanol-based forms at raising 25(OH)D, although results varied across studies (Grossmann and Tangpricha, 2010). In practice, a softgel with oil or a drop in oil is a reasonable choice, especially when not taken with a meal.

D3 versus D2. Several trials and meta-analyses found that vitamin D3 raises and maintains 25(OH)D better than D2, particularly with weekly or monthly dosing (Armas et al., 2004; Houghton and Vieth, 2006; Tripkovic et al., 2012).

Dosing schedule. Daily, weekly, and monthly dosing can all raise 25(OH)D, but very large, infrequent doses behave differently. In a trial of older women, a single annual dose of 500,000 IU was associated with more falls and fractures than placebo (Sanders et al., 2010). Daily or regular smaller doses are generally preferred.

Calcifediol. Because it skips the liver step, calcifediol raises 25(OH)D faster and more predictably. It is used in some countries as a prescription or supplement, particularly in malabsorption or liver disease.

Individual factors. Higher body mass, fat malabsorption (celiac disease, inflammatory bowel disease, bariatric surgery, cystic fibrosis), liver or kidney disease, genetic variants in genes such as GC, CYP2R1, and DHCR7, and low magnesium status can all change response. Skin pigmentation affects skin synthesis, not oral absorption.

Preclinical Evidence Summary for Vitamin D3

Laboratory and animal studies have built the biological case for vitamin D3 and shaped nearly every clinical question.

• Receptor and enzyme knockout models. Mice lacking the VDR or the CYP27B1 enzyme develop rickets-like bone changes, low calcium, and high PTH, confirming the central role of the vitamin D system in mineral balance. VDR-deficient mice also show hair loss, which points to roles beyond bone.
• Deficiency models. Animals fed vitamin D-deficient diets develop impaired bone mineralization and, in some studies, altered immune and metabolic responses.
• Immune and autoimmune models. Calcitriol and analogs reduce disease severity in several animal models of autoimmunity, such as experimental autoimmune encephalomyelitis and some models of colitis and type 1 diabetes.
• Infection models. Induction of cathelicidin and other antimicrobial responses has been observed in cells and some animal models.
• Cancer cell studies. In cell cultures and rodent tumors, calcitriol and analogs slow growth and promote differentiation, often at concentrations higher than those found in the blood of people.
• Cardiometabolic and muscle models. Studies point to effects on blood pressure regulation, vascular inflammation, insulin secretion, and muscle function.

Important limits apply (Bouillon et al., 2019). Many experiments use calcitriol or synthetic analogs at doses that would cause high blood calcium in people. Rodents differ from humans in vitamin D metabolism and are often nocturnal, so their skin synthesis differs. And a mechanism that works in a laboratory dish does not prove that a nutritional dose of cholecalciferol will change disease risk. That is why randomized trials are indispensable.

Human Clinical Evidence Summary for Vitamin D3

Human evidence includes observational studies, which link low 25(OH)D with many diseases, and randomized controlled trials (RCTs), which test whether giving vitamin D3 changes outcomes. Observational links are often confounded: people who are ill, obese, inactive, or housebound tend to have low vitamin D, so low levels may be a marker rather than a cause.

Rickets, osteomalacia, and deficiency. This is the clearest indication. Vitamin D prevents and treats rickets in children and osteomalacia in adults, and the benefit is not in dispute. Infants who are breastfed usually receive 400 IU daily to prevent rickets (Wagner and Greer, 2008).

Fractures and falls. Results are mixed. Cochrane reviews have found that vitamin D alone does not reliably prevent hip or other fractures in older adults, while vitamin D together with calcium may reduce some fractures, mainly in institutionalized or deficient people (Avenell et al., 2014). The large VITAL ancillary bone trial found that 2,000 IU per day did not reduce fractures in generally healthy adults (LeBoff et al., 2022). Calcium plus vitamin D in the Women's Health Initiative was associated with a small increase in kidney stones (Jackson et al., 2006).

Cancer and cardiovascular disease. The VITAL trial, with about 25,000 participants, found that 2,000 IU per day of vitamin D3 did not significantly reduce invasive cancer or major cardiovascular events over a median of 5.3 years (Manson et al., 2019). A meta-analysis found no clear benefit for cardiovascular outcomes (Barbarawi et al., 2019). Some meta-analyses suggest a possible reduction in cancer mortality but not incidence, which should be treated as a hypothesis (Keum et al., 2019).

Mortality. The D-Health trial in Australia, which gave monthly doses equivalent to about 2,000 IU per day, did not reduce overall mortality (Neale et al., 2022).

Respiratory infections. A meta-analysis of individual participant data from 25 trials found that vitamin D supplementation modestly reduced the risk of acute respiratory infection, with the greatest benefit in people who were deficient at baseline and who received daily or weekly doses rather than large bolus doses (Martineau et al., 2017). Evidence for COVID-19 outcomes remains inconclusive.

Type 2 diabetes. In the D2d trial of people with prediabetes, 4,000 IU daily did not significantly reduce progression to diabetes, although there was a trend toward benefit (Pittas et al., 2019). A pooled analysis of three trials suggested a modest reduction in risk (Pittas et al., 2023). This is an active area of study.

Autoimmune disease. A secondary analysis of VITAL found a lower rate of newly diagnosed autoimmune disease with vitamin D after five years, which is intriguing but requires confirmation (Hahn et al., 2022).

Depression and mood. The VITAL depression study found no benefit of 2,000 IU per day for preventing depression or improving mood in generally healthy adults (Okereke et al., 2020).

Pregnancy. A Cochrane review suggested that supplementation may lower the risk of pre-eclampsia, low birth weight, and some other complications, but the certainty of evidence is limited (Palacios et al., 2019). The MAVIDOS trial found that 1,000 IU daily in pregnancy increased neonatal bone mineral content in winter births (Cooper et al., 2016).

A general interpretation of these trials is important. Many large trials enrolled people who were not deficient, so they tested whether extra vitamin D benefits people who already have adequate levels. The answer was usually no. They do not show that treating true deficiency is unhelpful.

Evidence Grading by Outcome for Vitamin D3 Supplements

The table shows our editorial grading, based on trial size, consistency, and quality. It is not an official guideline.

Outcome	Evidence grade	Short interpretation
Preventing rickets and osteomalacia	Strong	Established; required for mineralization
Raising 25(OH)D in deficiency	Strong	Reliable at appropriate doses
Fractures in general healthy adults	Low	No benefit in VITAL bone study
Fractures in deficient or institutionalized older adults (with calcium)	Low to moderate	Some benefit in selected groups
Falls in older adults	Low and inconsistent	Mixed; high bolus doses may increase falls
Acute respiratory infections	Moderate	Modest benefit, mainly if deficient and with daily or weekly dosing
Cancer incidence	Low	No clear effect in large trials
Cancer mortality	Low	Possible signal; unconfirmed
Cardiovascular disease	Low	No clear benefit in large trials
Type 2 diabetes in prediabetes	Low to moderate	Modest possible benefit; active research
Autoimmune disease prevention	Low	Interesting secondary result; needs confirmation
Depression	Low	No benefit in prevention trial
Pregnancy outcomes	Low to moderate	Possible benefit; certainty limited
All-cause mortality	Low	No effect in large general population trials

Dosages of Vitamin D3 Used in Studies

The values below are drawn from published recommendations and trial protocols. They describe what was used in research or in guidelines, not what any individual should take.

Setting	Approximate dose	Notes
U.S. RDA, ages 1 to 70	600 IU (15 mcg) per day	Meets the needs of about 97 to 98 percent of healthy people
U.S. RDA, over age 70	800 IU (20 mcg) per day	Higher need with age
Infants (breastfed)	400 IU (10 mcg) per day	Standard preventive dose
U.S. Tolerable Upper Intake Level, adults	4,000 IU (100 mcg) per day	Level below which harm is unlikely
VITAL	2,000 IU per day	About 25,000 adults; 5.3-year median follow-up
D-Health	60,000 IU once per month	About 2,000 IU per day equivalent
D2d	4,000 IU per day	Adults with prediabetes
MAVIDOS	1,000 IU per day	Pregnancy
Annual bolus study	500,000 IU once per year	Associated with more falls and fractures
Treating deficiency (Endocrine Society 2011)	50,000 IU once weekly for several weeks, or about 6,000 IU daily, then maintenance of about 1,500 to 2,000 IU per day	Clinical use under medical supervision

Other authorities give different numbers. The European Food Safety Authority set an adequate intake of 15 mcg (600 IU) per day for people aged one year and older (EFSA, 2016), and the UK Scientific Advisory Committee on Nutrition recommended 10 mcg (400 IU) per day for people aged four and older (SACN, 2016). The 2024 Endocrine Society guideline suggests empiric supplementation for children, adults over 75, pregnant women, and people with high-risk prediabetes, and does not recommend routine testing or higher-than-RDA supplementation in healthy adults under 75 (Demay et al., 2024). These differences show why individual circumstances matter, and why a clinician can help decide.

Timing and Use of Vitamin D3 Supplements

Timing is simpler than marketing suggests. The key principles are:

• Take it with a meal that contains fat. Absorption is better with food, and for many people the largest meal is the most convenient choice (Mulligan and Licata, 2010).
• Time of day is flexible. There is no strong evidence that morning or evening is better. Consistency is more important. Some people report poorer sleep with evening doses, but this is anecdotal and not established.
• Prefer regular dosing. Daily or weekly dosing is generally preferred over very large occasional doses.
• Allow time. It takes about two to three months for 25(OH)D to reach a stable level, so rechecking a blood level sooner than that may be misleading.
• Consider the season. Needs are often higher in winter at higher latitudes and in people who rarely go outdoors. Some people use supplements only in the darker months.
• Count all sources. Add up vitamin D from multivitamins, fortified foods, cod liver oil, and separate vitamin D products to avoid unintentionally exceeding the upper limit.
• Store properly. Keep supplements in a cool, dry place out of direct light, and discard them after the expiry date.
• Test when it will change a decision. A 25(OH)D test is useful when there is a clinical reason, such as a bone disease, malabsorption, or a need to monitor high-dose treatment, rather than as a routine screen for everyone.
• Pair with a clinician when needed. People who take medicines, have kidney or parathyroid problems, or have a history of high calcium should check with a healthcare professional first.

Available Forms of Vitamin D3 Supplements

The market offers many formats, and the right one depends on age, swallowing ability, absorption, and diet.

Form	Typical use	Strengths	Limitations
Oil-filled softgel	Daily adult supplement	Fat carrier aids absorption; stable	Gelatin shell is not vegetarian unless plant-based
Tablet or capsule (beadlet)	Daily or weekly supplement	Compact; long shelf life	Carrier ingredients may matter for allergies
Liquid drops	Infants, children, people who cannot swallow pills	Flexible dosing	Dosing errors if the dropper is misused
Oral spray	Adults who prefer no pills	Convenient	Absorption evidence is limited
Gummy or chewable	Children and adults	Easy to take	Potency can drift; sugar content; easy to overconsume
High-dose capsule (weekly or monthly)	Treatment of deficiency under supervision	Convenient schedule	Not for routine self-dosing
Lichen-derived vegan D3	Vegan and vegetarian users	Same molecule as other D3	Usually higher price
Vitamin D2 (ergocalciferol)	Some prescriptions and fortified foods	Plant or fungal source	Generally less effective than D3
Calcifediol	Prescription or specialist use	Faster rise in 25(OH)D	Not an everyday product in all countries
Combination products	With calcium, magnesium, or vitamin K2	Convenient	Individual doses may not suit everyone; extra ingredients add interactions
Fortified foods and cod liver oil	Diet-based intake	Adds nutrients with food	Amounts vary; cod liver oil also contains vitamin A

A practical rule: choose the simplest product that provides the dose you and your clinician have agreed on, labeled clearly in mcg or IU, with minimal additives.

Safety and Side Effects of Vitamin D3

At recommended intakes, vitamin D3 has a strong safety record. The problems arise with excess.

Hypercalcemia. The main danger of too much vitamin D is high blood calcium. Symptoms include nausea, vomiting, loss of appetite, constipation, increased thirst and urination, weakness, confusion, and in severe cases kidney damage and abnormal heart rhythm. These problems are usually associated with very high doses taken for long periods and with 25(OH)D levels far above the usual range, often above about 150 ng/mL (375 nmol/L) (Marcinowska-Suchowierska et al., 2018).

Kidney stones and calcium excretion. Vitamin D increases calcium absorption, which can raise urinary calcium. In the Women's Health Initiative, women taking calcium and vitamin D together had a slightly higher rate of kidney stones (Jackson et al., 2006). People with a history of stones should discuss vitamin D and calcium use with a clinician.

Large infrequent doses. A trial in older women using 500,000 IU once a year found more falls and fractures with vitamin D than with placebo (Sanders et al., 2010). This is why extremely large single doses are not recommended outside medical supervision.

Upper limits. The U.S. Tolerable Upper Intake Level is 4,000 IU (100 mcg) per day for ages 9 and older, with lower limits for infants and younger children (1,000 IU for 0 to 6 months, 1,500 IU for 6 to 12 months, 2,500 IU for ages 1 to 3, and 3,000 IU for ages 4 to 8) (IOM, 2011). The upper limit is not a target, and it is not the same as the level at which harm becomes likely, but it is a prudent ceiling without supervision.

Product errors. Toxicity from supplements often results from manufacturing or labeling errors, or from taking multiple products without adding up the totals. Cases of severe hypercalcemia have been traced to mislabeled products (Araki et al., 2011), and an episode of over-fortified milk in the United States caused illness in several people (Jacobus et al., 1992).

Sun exposure. Sunlight does not cause vitamin D toxicity, because the skin limits its own production. Sun exposure carries other risks, such as skin damage and skin cancer.

Other effects. Mild digestive upset can occur with some products. Allergic reactions are usually due to additives, such as soy, gelatin, or dyes, and not to cholecalciferol itself. People with certain conditions, discussed below, may be more sensitive to calcium effects.

Anyone who develops symptoms of high calcium while taking vitamin D should stop the supplement and seek medical advice.

Vitamin D3 Drug and Supplement Interactions

Most people can take vitamin D3 with their regular medicines, but several interactions are worth knowing.

Medicine or supplement	Possible interaction	Practical point
Thiazide diuretics (for example hydrochlorothiazide)	Reduce urinary calcium loss; combined with vitamin D can raise blood calcium	Calcium levels may need monitoring
Digoxin and other cardiac glycosides	High blood calcium can increase the risk of arrhythmia	Clinician supervision advised
Calcium supplements and calcium-containing antacids	Additive calcium load	Count total calcium; relevant for kidney stone risk
Corticosteroids (for example prednisone)	Can reduce calcium absorption and affect vitamin D metabolism	Bone health is often reviewed with long-term use
Anticonvulsants (phenytoin, phenobarbital, carbamazepine)	Increase breakdown of vitamin D, lowering 25(OH)D	Higher needs possible; clinician guidance
Rifampin and some HIV medicines	Can increase vitamin D catabolism	Monitoring may be advised
Orlistat, cholestyramine, colestipol, mineral oil	Reduce absorption of fat-soluble vitamins	Separate timing, and discuss dose
Ketoconazole and related antifungals	May inhibit vitamin D activation	Clinical review in long-term use
Activated vitamin D drugs (calcitriol, calcipotriol, calcifediol)	Additive effects	Avoid duplication without medical advice
Magnesium	Needed for vitamin D activation	Low magnesium may blunt response
High-dose vitamin A	Possible interaction at high intakes	Avoid excessive combined intake

Because lists like this are broad, the safest habit is to bring all product labels to a pharmacist or physician, particularly when you take prescription medicines or have kidney, heart, or parathyroid conditions. Some interactions are well established, while others are theoretical, and the level of concern depends on the dose.

Special Populations: Who Needs Extra Care With Vitamin D3

Infants. Breastfed and partially breastfed infants are commonly advised to take 400 IU daily from the first days of life, since breast milk contains little vitamin D (Wagner and Greer, 2008). Dosing must be exact, and a pediatric clinician should guide it.

Children and adolescents. Needs follow the RDA for age. Clinical guidelines suggest that supplementation may be appropriate in some groups, such as those with limited sun exposure.

Pregnancy and breastfeeding. The U.S. RDA is 600 IU, and the upper limit is 4,000 IU. Evidence for broader benefits is limited, and dose should be discussed with the care team (Palacios et al., 2019).

Older adults. Skin synthesis declines, intake is often lower, and the RDA rises to 800 IU after age 70. Clinicians consider vitamin D together with calcium, protein, exercise, and fall prevention.

People with darker skin or limited sun exposure. Higher melanin reduces skin synthesis, and covering clothing, indoor work, and high latitude add to the effect. Individual testing and tailored advice are reasonable.

People with obesity or after bariatric surgery. Larger body fat stores dilute the vitamin, and malabsorption may occur after surgery. Needs may be higher, and monitoring is often recommended.

Malabsorption, liver disease, or kidney disease. Cystic fibrosis, celiac disease, inflammatory bowel disease, and cholestatic liver disease reduce absorption. Advanced kidney disease reduces conversion to calcitriol, so activated forms are often needed. Management should be specialist-led.

Sarcoidosis, tuberculosis, lymphoma, and other granulomatous conditions. These conditions can increase local production of calcitriol, so even ordinary vitamin D doses may raise calcium. Medical supervision is essential.

Primary hyperparathyroidism and a history of high calcium or kidney stones. Vitamin D can worsen high calcium, so decisions should be individualized.

Rare genetic conditions. Variants in the CYP24A1 gene can impair vitamin D breakdown and cause sensitivity to usual doses.

Vegans and vegetarians. Fortified foods and lichen-derived or other vegan vitamin D3 can fill the gap, as dietary sources are limited.

Quality, Testing, and Authentication of Vitamin D3 Supplements

A supplement is only as reliable as its manufacturing. Independent analysis has found that actual vitamin D content can differ greatly from the label. One study of over-the-counter and compounded products found potency ranging widely above and below the stated amount (LeBlanc et al., 2013).

Quality checks used by laboratories include:

• HPLC or LC-MS/MS to confirm identity and quantity of cholecalciferol.
• Content uniformity testing to ensure each capsule or drop contains a consistent dose.
• Stability studies to confirm that potency persists to the expiry date.
• Contaminant testing for heavy metals, pesticide residues, solvents, and microbes.
• Disintegration and dissolution tests for tablets and capsules.

For consumers, helpful practices include:

• Look for independent third-party verification, such as programs from USP or NSF, or a published certificate of analysis for the batch.
• Confirm that the label states vitamin D3 (cholecalciferol) and gives the dose in mcg or IU per serving.
• Choose a product with a clear lot number and expiry date.
• Be careful with products that offer very high doses per serving, proprietary blends that hide amounts, or health claims that sound like treatment promises.
• Check allergen information, including gelatin, soy, dairy, and shellfish-derived or lanolin-derived statements for those who avoid animal sources.

For source authentication, vegan or lanolin-derived claims are generally verified through supplier documentation and audits, not by a simple consumer test. Seals do not guarantee perfection, and combining several signals offers the best protection.

Adulteration and Contamination Risks in Cholecalciferol Products

Two kinds of problems appear: accidental quality failures and deliberate misrepresentation.

Potency errors. The most important risk is wrong dosing, either too little, which makes the product ineffective, or too much, which can be dangerous. Cases of severe hypercalcemia have followed production and labeling errors (Araki et al., 2011), and over-fortification of milk has caused vitamin D poisoning in the past (Jacobus et al., 1992).

Substitution and mislabeling. A product may be labeled as vitamin D3 while containing D2, or may be labeled vegan when it is not. Some products use confusing units or list a dose per several capsules without making that clear.

Contaminants from raw materials. Lanolin can carry pesticide residues from sheep dips and the environment, and purification steps are designed to remove them. Lichens can accumulate heavy metals and pollutants from the air and substrate, so testing of raw lichen and final extracts matters. Residual solvents from extraction and crystallization are controlled in good manufacturing practice.

Excipient and allergen problems. Hidden allergens, such as soy, milk, gluten, or fish oil carriers, can be a risk for sensitive people. Gummies may contain high sugar, sugar alcohols, and colorants.

Degradation. Heat, light, and moisture break down cholecalciferol, so poorly stored products can lose potency. Gummies and liquids are more vulnerable.

Counterfeit and unregulated products. Products bought from unverified online sellers, or compounded without proper testing, can differ from the label.

Reducing risk means buying from transparent manufacturers, checking for independent testing, avoiding megadose products without a medical reason, and storing supplements correctly.

Regulatory Overview of Vitamin D3

Regulation varies by country, so readers should verify current rules with the relevant authority.

United States. Vitamin D3 supplements are regulated as dietary supplements under the Dietary Supplement Health and Education Act of 1994. Manufacturers are responsible for safety and truthful labeling, and the FDA does not approve supplements before they are sold. Supplements may carry structure and function claims, with a required disclaimer, but may not claim to treat or cure disease. The FDA's revised Nutrition and Supplement Facts label rule requires vitamin D to be listed in micrograms, with a Daily Value of 20 mcg (FDA, 2016). Milk and other foods may be fortified under FDA rules, and high-dose vitamin D products sold as drugs are regulated under drug laws. Dietary reference values come from the National Academies (IOM, 2011).

European Union. The European Food Safety Authority set an adequate intake of 15 mcg (600 IU) per day for people aged one year and older (EFSA, 2016) and a tolerable upper intake level of 100 mcg (4,000 IU) per day for adults and adolescents aged 11 and older, 50 mcg for ages 1 to 10, and 25 mcg for infants (EFSA, 2012). Authorized health claims for vitamin D include contributions to normal calcium absorption, normal bones, teeth, and muscle function, normal immune system function, and normal cell division, subject to conditions of use. National rules on maximum supplement doses differ across member states.

United Kingdom. The Scientific Advisory Committee on Nutrition recommended a reference intake of 10 mcg (400 IU) per day for people aged four and older (SACN, 2016), and public health advice suggests that many people consider a daily supplement during autumn and winter, with year-round use for higher-risk groups.

Other regions. Health Canada, Australia's Therapeutic Goods Administration, and agencies in Asia regulate vitamin D3 as natural health or complementary medicine products, with quality rules and claim restrictions. Some countries mandate or encourage fortification of milk, margarine, or flour.

Because policy can change, the most reliable sources for current rules are the agencies themselves.

Research Gaps in Vitamin D3 Science

Despite thousands of publications, important questions remain.

1. Optimal blood levels. Experts disagree on target 25(OH)D concentrations for bone and non-bone outcomes, and thresholds may differ by age, ancestry, and health status.
2. Total versus free vitamin D. Vitamin D binding protein varies by genetics and ancestry, so total 25(OH)D may not equal the biologically available fraction.
3. Trials in deficient populations. Many large trials enrolled people with adequate baseline levels, so benefits in deficient or high-risk groups are less certain.
4. Dose and schedule. The best dosing frequency and whether higher daily doses help specific outcomes are still unclear.
5. Assay standardization. Differences between laboratory methods complicate comparisons.
6. Extraskeletal outcomes. Evidence for immune, autoimmune, cancer mortality, metabolic, and mood outcomes needs larger and longer trials.
7. Combination nutrients. Interactions with magnesium, vitamin K, calcium, and vitamin A need systematic study.
8. Genetic and metabolic differences. Variants in genes for vitamin D transport and metabolism may explain different responses.
9. Long-term high-dose safety. Effects on falls, kidney stones, and vascular calcification at higher doses over many years need more data.
10. Balancing sun and supplements. Better guidance is needed on how to weigh skin cancer risk against vitamin D synthesis in different populations.

FAQ: Vitamin D3 and Cholecalciferol

How much vitamin D3 should I take per day?

The U.S. RDA is 600 IU (15 mcg) for most adults up to age 70 and 800 IU (20 mcg) afterward, with an upper limit of 4,000 IU (100 mcg). Individual needs vary, so ask a clinician if you have a deficiency, a medical condition, or limited sun exposure.

What is the difference between vitamin D3 and vitamin D2?

Both are forms of vitamin D. D3 (cholecalciferol) comes from animals and lichens and is made in human skin, while D2 (ergocalciferol) comes from plants and fungi. Studies generally show that D3 raises blood 25(OH)D more effectively.

Should I take vitamin D3 with food?

Yes, with a meal that contains some fat is a good approach, because absorption tends to improve.

Do vitamin D3 supplements prevent colds, cancer, or heart disease?

The evidence differs. Daily or weekly doses may modestly reduce respiratory infections, mainly in people who are deficient. Large trials have not shown clear protection against cancer incidence or heart disease in generally healthy adults.

Can I get enough vitamin D from the sun?

Some people can, depending on season, latitude, skin tone, age, and time outdoors. Because unprotected sun exposure raises skin cancer risk, health authorities do not recommend it as a deliberate strategy.

Should I take vitamin D3 with vitamin K2 or magnesium?

Magnesium is a cofactor for vitamin D activation, so low magnesium may blunt response. The idea that vitamin K2 should always accompany vitamin D3 is an active research area, and evidence for added benefit in healthy people is limited. Discuss combinations with a clinician, particularly if you take warfarin.

Can you take too much vitamin D3?

Yes. Excess can raise blood calcium and cause nausea, weakness, kidney problems, and other complications. Staying at or below the upper limit unless a clinician advises otherwise lowers the risk, as does counting all sources.

Do I need a blood test?

Not everyone does. A 25(OH)D test is most useful when there is a clinical reason, such as bone disease, malabsorption, kidney or liver disease, or monitoring of high-dose treatment. Current guidelines do not recommend routine testing for healthy people.

Are gummies as good as capsules?

Gummies can supply vitamin D3, but potency may drift in storage and they may include sugar. Choose a product with third-party testing, and keep it away from children.

Is vitamin D3 safe for children?

In appropriate doses, yes. Infants commonly receive 400 IU daily, and children have age-specific limits. Dosing should be guided by a pediatric clinician.

Scientific References

Links are given only where we are confident of a stable public address. Please verify each citation in PubMed or the publisher's site before publication.

1. Araki T, Holick MF, Alfonso BD, et al. Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States. J Clin Endocrinol Metab. 2011;96(12):3603-3608.
2. Armas LAG, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89(11):5387-5391.
3. Avenell A, Mak JC, O'Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. 2014;(4):CD000227.
4. Barbarawi M, Kheiri B, Zayed Y, et al. Vitamin D supplementation and cardiovascular disease risks in more than 83,000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiol. 2019;4(8):765-776.
5. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319-329.
6. Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev. 2019;40(4):1109-1151.
7. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96(1):365-408.
8. Cooper C, Harvey NC, Bishop NJ, et al. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. Lancet Diabetes Endocrinol. 2016;4(5):393-402.
9. Dawson-Hughes B, Harris SS, Lichtenstein AH, et al. Dietary fat increases vitamin D-3 absorption. J Acad Nutr Diet. 2015;115(2):225-230.
10. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947.
11. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on the tolerable upper intake level of vitamin D. EFSA J. 2012;10(7):2813.
12. EFSA Panel on Dietetic Products, Nutrition and Allergies. Dietary reference values for vitamin D. EFSA J. 2016;14(10):4547.
13. U.S. Food and Drug Administration. Food labeling: revision of the Nutrition and Supplement Facts labels. Fed Regist. 2016;81(103):33742-33999.
14. Fraser DR, Kodicek E. Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature. 1970;228:764-766.
15. Grossmann RE, Tangpricha V. Evaluation of vehicle substances on vitamin D bioavailability: a systematic review. Mol Nutr Food Res. 2010;54(8):1055-1061.
16. Hahn J, Cook NR, Alexander EK, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452.
17. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204-210.
18. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
19. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
20. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr. 2006;84(4):694-697.
21. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011.
22. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669-683.
23. Jacobus CH, Holick MF, Shao Q, et al. Hypervitaminosis D associated with drinking milk. N Engl J Med. 1992;326(18):1173-1177.
24. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88(2):582S-586S.
25. Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019;30(5):733-743.
26. LeBlanc ES, Perrin N, Johnson JD, Ballatore A, Hillier T. Over-the-counter and compounded vitamin D: is potency what we expect? JAMA Intern Med. 2013;173(7):585-586.
27. LeBoff MS, Chou SH, Ratliff KA, et al. Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med. 2022;387(4):299-309.
28. Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33-44.
29. Marcinowska-Suchowierska E, Kupisz-Urbanska M, Lukaszkiewicz J, Pludowski P, Jones G. Vitamin D toxicity: a clinical perspective. Front Endocrinol. 2018;9:550.
30. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.
31. Mazahery H, von Hurst PR. Factors affecting 25-hydroxyvitamin D concentration in response to vitamin D supplementation. Nutrients. 2015;7(7):5111-5142.
32. McCollum EV, Simmonds N, Becker JE, Shipley PG. Studies on experimental rickets. XXI. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem. 1922;53:293-312.
33. Mulligan GB, Licata A. Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D. J Bone Miner Res. 2010;25(4):928-930.
34. Neale RE, Baxter C, Romero BD, et al. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol. 2022;10(2):120-128.
35. National Institutes of Health, Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
36. Okereke OI, Reynolds CF 3rd, Mischoulon D, et al. Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores (VITAL-DEP). JAMA. 2020;324(5):471-480.
37. Palacios C, Kostiuk LK, Pena-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019;7:CD008873.
38. Pittas AG, Dawson-Hughes B, Sheehan P, et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019;381(6):520-530.
39. Pittas AG, Kawahara T, Jorde R, et al. Vitamin D and risk for type 2 diabetes in people with prediabetes: a systematic review and meta-analysis of individual participant data from 3 randomized clinical trials. Ann Intern Med. 2023;176(3):355-363.
40. Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics. 2003;112(2):e132-e135.
41. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-58.
42. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303(18):1815-1822.
43. Scientific Advisory Committee on Nutrition (SACN). Vitamin D and Health. London: Public Health England; 2016.
44. Sempos CT, Heijboer AC, Bikle DD, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. Br J Clin Pharmacol. 2018;84(10):2194-2207.
45. Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357-1364.
46. Uwitonze AM, Razzaque MS. Role of magnesium in vitamin D activation and function. J Am Osteopath Assoc. 2018;118(3):181-189.
47. Wacker M, Holick MF. Sunlight and vitamin D: a global perspective for health. Dermatoendocrinol. 2013;5(1):51-108.
48. Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122(5):1142-1152.
49. Wolf G. The discovery of vitamin D: the contribution of Adolf Windaus. J Nutr. 2004;134(6):1299-1302.

Related Content and Next Steps for Vitamin D3 Readers

This guide is the central reference for our vitamin D3 content. If you have read this far, the most useful next step is to turn the science into a personal plan with a qualified professional. Consider the following actions:

1. Review your own situation. Note your age, sun exposure, skin tone, diet, medicines, and health conditions.
2. Count your current intake. Add up vitamin D from multivitamins, fortified foods, and any separate vitamin D3 supplements.
3. Ask whether testing is useful. A 25(OH)D test makes sense when it will change a decision.
4. Choose quality. Use the checklist in the quality section to compare products by labeled dose, form, third-party testing, and additives.
5. Talk to a healthcare professional before starting, especially in pregnancy, kidney or heart disease, high calcium, or when taking regular medicines.

To explore specific questions, we suggest the following related pages [add internal links when published]:

Related topic	What it covers
Vitamin D3 dosage guide	How doses were chosen in guidelines and trials, by age and situation
Vitamin D3 interactions	A conservative reference to drug, supplement, food, and laboratory interactions
Vitamin D3 vs D2	Detailed comparison of forms and evidence
Vitamin D3 and K2	What is known and unknown about combination products
Magnesium and vitamin D	The role of magnesium in vitamin D activation
How to read a supplement label	Units, serving sizes, additives, and testing marks
Vitamin D testing explained	Understanding 25(OH)D results and reference ranges
Omega-3 fatty acids guide	A companion pillar page on another widely used nutrient

This page is educational, not promotional. It does not recommend a specific brand or product, and nothing here should be taken as a claim that vitamin D3 supplements can diagnose, treat, cure, or prevent any disease. For personal medical decisions, consult a qualified healthcare professional.